Suchergebnisse - "Liu, Xiaoqing"

PubPharm (15)

1

Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib : Results of Phase 3 ALTA-3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Yang, J. | Liu, G. | Lu, S. | +11

2

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: The New England journal of medicine | 2023

von Tsuboi, M. | Herbst, R. | John, T. | +118

CommentIn: Nat Rev Clin Oncol. 2023 Aug;20(8):504. - PMID 37311902

3

MRI-based two-stage deep learning model for automatic detection and segmentation of brain metastases

enthalten in: European radiology | 2023

von Li, R. | Guo, Y. | Zhao, Z. | +4

4

Use of a coronary guidewire to facilitate transseptal puncture : A randomized comparison with a conventional technique

enthalten in: Pacing and clinical electrophysiology : PACE | 2022

von Liu, L. | Wang, Y. | Liu, Z. | +5

5

Development and validation of a clinical risk model to predict the hospital mortality in ventilated patients with acute respiratory distress syndrome : a population-based study

enthalten in: BMC pulmonary medicine | 2022

von Ye, W. | Li, R. | Liang, H. | +7

6

Optimized cutoffs of gamma-glutamyl transpeptidase-to-platelet ratio, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 scoring systems for exclusion of cirrhosis in patients with chronic hepatitis B

enthalten in: Hepatology communications | 2022

von Liu, X. | Li, H. | Wei, L. | +2

7

Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC : a multicenter phase-II trial

enthalten in: Signal transduction and targeted therapy | 2021

von Jiang, T. | Wang, P. | Zhang, J. | +22

8

Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von He, J. | Su, C. | Liang, W. | +30

9

Efficacy and Safety of Niraparib as Maintenance Treatment in Patients With Extensive-Stage SCLC After First-Line Chemotherapy : A Randomized, Double-Blind, Phase 3 Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Ai, X. | Pan, Y. | Shi, J. | +34

CommentIn: J Thorac Oncol. 2021 Aug;16(8):1236-1238. - PMID 34304849

10

Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer : Results from a randomized, open-label, phase 3 trial (ARCHER 1050)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Cheng, Y. | Mok, T. | Zhou, X. | +17